Caplacizumab Treatment in Elderly Patients with iTTP: Updated Experience from the Spanish TTP Registry

MLA

Gómez Seguí, Inés, et al. “Caplacizumab Treatment in Elderly Patients with ITTP: Updated Experience from the Spanish TTP Registry.” Blood, vol. 142, no. 1, Number 1 Supplement 1, Nov. 2023, p. 5429. EBSCOhost, https://doi.org/10.1182/blood-2023-180970.

APA

Gómez Seguí, I., Sopeña Pell-Ilderton, C., Cid, J., Lozano, M., Mingot Castellano, M. E., Pascual Izquierdo, M. C., Gonzalez del Castillo, L. M., Vidan Estevez, J. M., Garcia-Candel, F., Jiménez Balarezo, M., Valcarcel, D., Cuellar Perez-Avila, C., Aguirre Arrizabalaga, M. A., Avila Idrovo, L. F., Moreno Jimenez, M. G., Oliva Hernandez, A. Y., Garcia Gala, J. M., Martínez Nieto, J., Goterris, R., … De La Rubia, J. (2023). Caplacizumab Treatment in Elderly Patients with iTTP: Updated Experience from the Spanish TTP Registry. Blood, 142(1, Number 1 Supplement 1), 5429. https://doi.org/10.1182/blood-2023-180970

Chicago

Gómez Seguí, Inés, Clara Sopeña Pell-Ilderton, Joan Cid, Miquel Lozano, Maria Eva Mingot Castellano, Maria Cristina Pascual Izquierdo, Luz Maria Gonzalez del Castillo, et al. 2023. “Caplacizumab Treatment in Elderly Patients with ITTP: Updated Experience from the Spanish TTP Registry.” Blood 142 (1, Number 1 Supplement 1): 5429. doi:10.1182/blood-2023-180970.